| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FMR LLC | 15% | +63.3% | $30,582,610 | +$11,592,390 | 6,318,721 | +61% | FMR LLC | 31 Jan 2025 |
| ACORN BIOVENTURES, L.P. | 5.2% | $14,115,428 | 2,580,517 | Anders Hove | 25 Jun 2025 | |||
| BAKER BROS. ADVISORS LP | 4.99% | -25.9% | $11,882,723 | -$2,550,075 | 2,455,108 | -17.7% | Baker Bros. Advisors LP | 31 Mar 2025 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Change | Price | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 22,652,478 | $115,539,883 | -$1,871,335 | $5.1 | 80 |
| 2025 Q2 | 23,037,394 | $116,569,933 | +$8,831,720 | $5.06 | 78 |
| 2025 Q1 | 21,190,126 | $119,726,836 | +$12,537,033 | $5.65 | 82 |
| 2024 Q4 | 17,950,985 | $155,743,026 | +$97,379,454 | $8.68 | 70 |
| 2024 Q3 | 6,693,196 | $46,384,699 | +$3,074,083 | $6.93 | 51 |
| 2024 Q2 | 5,961,761 | $36,964,279 | +$13,959,987 | $6.2 | 45 |
| 2024 Q1 | 3,780,257 | $5,972,529 | -$231,572 | $1.58 | 18 |
| 2023 Q4 | 4,027,160 | $5,919,504 | -$1,196,574 | $1.47 | 21 |
| 2023 Q3 | 5,257,852 | $4,856,205 | -$147,500 | $0.92 | 19 |
| 2023 Q2 | 5,370,044 | $6,766,125 | -$142,743 | $1.26 | 19 |
| 2023 Q1 | 5,478,268 | $7,437,200 | +$69,459 | $1.35 | 20 |
| 2022 Q4 | 5,420,630 | $9,702,154 | -$1,788,500 | $1.79 | 20 |
| 2022 Q3 | 6,080,809 | $19,096,287 | -$834,398 | $3.14 | 22 |
| 2022 Q2 | 6,345,954 | $20,561,000 | -$1,159,878 | $3.24 | 21 |
| 2022 Q1 | 6,674,026 | $33,969,000 | -$1,719,786 | $5.08 | 21 |
| 2021 Q4 | 6,951,728 | $54,359,000 | +$875,765 | $7.82 | 20 |
| 2021 Q3 | 4,884,284 | $52,945,000 | +$44,146,000 | $10.84 | 12 |